Connor, Clark & Lunn Investment Management (CC&L)’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-49,770
| Closed | -$3.49M | – | 1446 |
|
|
2024
Q1 | $3.49M | Sell |
49,770
-80,702
| -62% | -$5.66M | 0.02% | 512 |
|
|
2023
Q4 | $10.9M | Sell |
130,472
-37,505
| -22% | -$3.13M | 0.05% | 261 |
|
|
2023
Q3 | $4.95M | Buy |
167,977
+45,624
| +37% | +$1.34M | 0.03% | 404 |
|
|
2023
Q2 | $3.99M | Sell |
122,353
-45,229
| -27% | -$1.48M | 0.02% | 439 |
|
|
2023
Q1 | $5.9M | Buy |
167,582
+5,726
| +4% | +$201K | 0.03% | 336 |
|
|
2022
Q4 | $7.42M | Buy |
161,856
+97,572
| +152% | +$4.47M | 0.04% | 276 |
|
|
2022
Q3 | $3.12M | Sell |
64,284
-29,555
| -31% | -$1.43M | 0.02% | 412 |
|
|
2022
Q2 | $3.69M | Buy |
93,839
+10,574
| +13% | +$415K | 0.02% | 366 |
|
|
2022
Q1 | $3.07M | Sell |
83,265
-14,833
| -15% | -$546K | 0.02% | 408 |
|
|
2021
Q4 | $4.47M | Buy |
+98,098
| New | +$4.47M | 0.02% | 355 |
|
|
2014
Q2 | – | Sell |
-141,043
| Closed | -$1.48M | – | 551 |
|
|
2014
Q1 | $1.48M | Sell |
141,043
-61,300
| -30% | -$643K | 0.01% | 317 |
|
|
2013
Q4 | $1.4M | Buy |
202,343
+113,193
| +127% | +$781K | 0.01% | 316 |
|
|
2013
Q3 | $694K | Buy |
+89,150
| New | +$694K | 0.01% | 316 |
|